Where to Find Reliable Peptide Information
The peptide information landscape is fragmented. Vendor marketing, Reddit anecdotes, academic papers, and government databases each have strengths — but none provide the complete picture. Here's how the sources compare.
The Information Gap
Vendor Marketing
Optimized to sell products. Purity claims without context. Regulatory status often outdated or misleading. No incentive to discuss risks.
Reddit & Forums
Valuable community experience, but no editorial standards. Anecdotes mixed with misinformation. Hard to verify claims. No systematic coverage.
Academic Papers
Gold standard for evidence, but inaccessible to most people. No practical guidance. No regulatory context. No way to compare compounds quickly.
Source Comparison
Strong coverage Partial or inconsistent Not available
| Criteria | TruPeptide | Vendor Sites | Health Platforms | PubMed | FDA.gov | |
|---|---|---|---|---|---|---|
Editorial Independence Free from commercial influence | ||||||
Compound Depth Detailed profiles with mechanisms, risks, FDA status | ||||||
Regulatory Tracking Up-to-date FDA status, PCAC timeline, key dates | ||||||
Dosing Protocols Routes, doses, cycle lengths, practical notes | ||||||
COA Guidance How to verify purity and quality | ||||||
Structured Data Searchable, filterable, machine-readable | ||||||
Community Experience Real user reports and discussions | ||||||
Primary Research Original clinical trial data and papers |
What TruPeptide Does Differently
No Commercial Relationships
We don't sell peptides, accept vendor sponsorships, or earn affiliate commissions. Trust scores are calculated from verified data, not paid placements. Our editorial policy documents the methodology.
Real-Time Regulatory Tracking
The FDA Tracker is updated the same day regulatory events happen. Every compound profile shows current FDA status with context — not just a label, but what it means for access.
80 Compound Profiles
Each profile includes mechanism of action, common uses, known risks, FDA status, cited studies, dosing protocols, and related compounds. 21 FDA-approved, 14 pending PCAC review, and growing.
Both Sides of the Evidence
Every compound profile includes known risks alongside potential uses. We link to primary research and note when evidence is limited or preclinical. We don't make efficacy claims — we report what the research says.
What Other Sources Do Well
No single source has everything. Here's where other resources genuinely excel — and we encourage you to use them alongside TruPeptide.
Real user experiences, community support, and rapid information sharing. The best place to hear what people are actually experiencing — just verify claims against published data.
The gold standard for primary research. When you need the original clinical trial data, PubMed is irreplaceable. We link to relevant studies in every compound profile.
The authoritative source for regulatory decisions. When the FDA publishes a final rule, that's the definitive word. We track and translate these decisions into plain language.
Start with the data
Browse 80 compound profiles, track the PCAC timeline, or compare compounds side by side. Everything is free, no account required.
This page is for educational purposes. TruPeptide is not a medical resource and does not provide medical advice. Always consult a licensed healthcare provider before making decisions about peptide therapy. See our editorial policy and disclaimer for more information.